» Authors » Zhenwei Deng

Zhenwei Deng

Explore the profile of Zhenwei Deng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Pan T, Guo G, Chen G, Cai Y, Tang Y, et al.
J Gastrointest Oncol . 2023 Jan; 13(6):2832-2844. PMID: 36636064
Background: Long non-coding ribonucleic acids (lncRNAs) are a class of non-coding RNAs implicated in the development of many malignancies, including gastric cancer (GC). In this study, we investigated the functions...
2.
Lu W, Xing J, Sun Y, Huang Q, Deng Z, Mao J
Org Biomol Chem . 2021 Nov; 19(46):10210-10214. PMID: 34806101
Catalytic carbonyl formation ranks as one of the most important synthetic methodologies. Herein, a highly effective palladium-catalyzed and alcohol-promoted transformation of nitriles to synthesize benzocyclic ketones is described. It provides...
3.
Yang F, Chen X, Li X, Chen J, Tang Y, Cai Y, et al.
Cancer Manag Res . 2020 Aug; 12:5587-5596. PMID: 32753971
Aim: To explore the expression and biological function of long intergenic non-protein coding RNA 1089 (LINC01089) in gastric cancer (GC) progression and its underlying mechanism. Methods: LINC01089 and microRNA-27a-3p (miR-27a-3p)...
4.
Deng Z, Li X, Wang H, Geng Y, Cai Y, Tang Y, et al.
Front Genet . 2020 Jun; 11:357. PMID: 32508871
This study was aimed to evaluate the potential function of circ-0001946 in the progression of colorectal cancer (CRC) and the related regulatory mechanism. First, the expression levels of circRNA_0001946 and...
5.
Deng Z, Wang H, Guo G, Li X, Cai Y, Tang Y, et al.
Med Sci Monit . 2019 Apr; 25:2386-2396. PMID: 30938333
BACKGROUND Cisplatin-resistant gastric cancer (GC) occurs in patients with GC treated with cisplatin-based chemotherapy, which results in disease progression and early recurrence during the treatment. MATERIAL AND METHODS To understand...
6.
Wang H, Deng Z, Chen X, Cai J, Ma T, Zhong Q, et al.
Med Sci Monit . 2019 Mar; 25:2169-2178. PMID: 30904920
BACKGROUND Doxorubicin (DOX) is a potent chemotherapeutic agent used to treat colon cancer. Despite impressive initial clinical responses, drug resistance has dramatically compromised the effectiveness of DOX. However, the underlying...
7.
Xiong W, Deng Z, Tang Y, Deng Z, Li M
Biochem Biophys Res Commun . 2018 Sep; 504(1):129-136. PMID: 30177394
Purpose: Histone lysine methyltransferase 2D (KMT2D/MLL2) is a known cancer-related protein; however, its function in gastric cancer (GC) remains uncharacterized. The present study sought to investigate the expression pattern and...
8.
Ren H, Xu Z, Guo W, Deng Z, Yu X
Biochem Biophys Res Commun . 2018 Jul; 503(4):2563-2568. PMID: 30005870
RAB3A interacting protein (Rab3IP) has been determined to be involved in cancer progression; however, its expression pattern and function in gastric cancer remain unknown. The aim of this study was...
9.
Lu X, Hu Y, Liu H, Mou T, Deng Z, Wang D, et al.
J Surg Res . 2015 Oct; 200(2):435-43. PMID: 26421708
Background: To assess the short-term outcomes of intracorporeal Roux-en-Y esophagojejunostomy using the transorally inserted anvil (OrVil) compared with extracorporeal circular Roux-en-Y anastomosis during laparoscopic total gastrectomy (LTG) for gastric cancer....
10.
Yan J, Zheng X, Liu Z, Yu J, Deng Z, Xue F, et al.
Surg Endosc . 2015 Jul; 30(4):1294-300. PMID: 26150223
Background: Lymph node metastasis occurs in approximately 10% of early gastric cancer. Preoperative or intra-operative identification of lymph node metastasis in early gastric cancer is crucial for surgical planning. The...